Drug Type Bispecific antibody |
Synonyms ORI A362, ORI-A362 |
Target |
Action agonists, inhibitors |
Mechanism 4-1BB agonists(Tumor necrosis factor receptor superfamily member 9 agonists), CLDN18.2 inhibitors(Claudin 18.2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedIND Application |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Solid tumor | IND Application | China | - |






